Health Condition 1: H521- Myopia
Conditions
Interventions
Intervention1: Jaborandi 30C: Oral route of administration pill form 30 number pill size centesimal scale first dose after case taking subsequent doses after each follow up and potency according to th
Sponsors
Bakson Homoeopathic Medical College And Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1) Participants of age group 8 to 18 years 2) Participants irrespective of their gender, religion and socioeconomic status. 3)Participants with diagnosed mild myopia (till -3D) and moderate myopia (-3D to -6D) 4) During the study if the participants is suffering with acute episodes of eye problems like dry eye syndrome, conjunctivitis & digital eye strain. 4) Participants who are willing to give assent for the study.
Exclusion criteria
Exclusion criteria: 1)Participants suffering from cataract, strabismus and any eye injury. 2) Participants with severe systemic illness any immune compromised condition any psychiatric issues under any substance abuse and severe endocrine disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Possible expectation of this research is that it will ensure the effectiveness of Jaborandi 30CH in managing myopia and changes will be analyzed from refraction error by an autorefractor.Timepoint: LVP-FVQ questionnaire and refractive error will be assessed at baseline, 12th week and 24th week Study duration 15 months a)Survey, Identification & Enrollment period: 6 months b)Follow up: 6 months c) Data Analysis & report writing : 3 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| Study will assess the effectiveness of a rare unidentified medicine Jaborandi in myopiaTimepoint: Study duration 15 months a)Survey, Identification & Enrollment period: 6 months b)Follow up: 6 months c) Data Analysis & report writing : 3 Months | — |
Countries
India
Contacts
Public ContactDr Puneet Garg
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed